Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
04:22:23 EDT Sun 13 Jul 2025
Enter Symbol
or Name
USA
CA



Q:AGNPF - ALGERNON PHARMACEUTICALS INC - https://algernonpharmaceuticals.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
AGNPF - Qnot subscribed0.03969-0.00931-19.065.5370.049  0.049  0.039690.105  0.03610:23:36Jun 3015 min RT 2¢

Recent Trades - All 7 today
Time ETExPriceChangeVolume
10:23:36Q0.04235-0.0066560
10:09:50Q0.03969-0.009311,600
09:38:59Q0.0441-0.004910,000
09:38:57Q0.049 10,430
09:38:57Q0.049 36,000
09:38:56Q0.049 3,709
09:38:56Q0.049 3,709
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-06-30 17:29U:AGNPFNews ReleaseAlgernon Announces Amended Terms for Private Placement and Closing of the First Tranche totaling $621,000
2025-05-27 07:00U:AGNPFNews ReleaseAlgernon Announces $1M Private Placement
2025-05-22 20:50U:AGNPFNews ReleaseAlgernon Closes NoBrainer Imaging Centers, Inc. Acquisition
2025-05-13 07:00U:AGNPFNews ReleaseAlgernon to Acquire NoBrainer Imaging Centers, Inc. - Plans to Establish Alzheimer's Diagnostic and Treatment Medical Clinics Featuring New PET Scan Technology
2025-05-05 07:48U:AGNPFNews ReleaseAlgernon Announces Warrant Extension
2025-04-08 07:00U:AGNPFNews ReleaseAlgernon Pharmaceuticals Receives Notice of Allowance from European Patent Office for Repirinast for Kidney Disease
2025-03-06 07:00U:AGNPFNews ReleaseAlgernon NeuroScience Engages Netcapital Securities for Planned Regulation A Financing
2025-02-11 07:00U:AGNPFNews ReleaseAlgernon NeuroScience Appoints Globally Recognized DMT Researcher and Clinician Dr. Sandor Nardai as Principal Investigator for Planned Phase 2a DMT Human Stroke Study
2025-02-05 07:00U:AGNPFNews ReleaseAlgernon NeuroScience Appoints Validcare as CRO for its Phase 2a DMT Human Stroke Trial and Announces Validcare's USD $170K Equity Investment
2025-01-06 07:00U:AGNPFNews ReleaseAlgernon Pharmaceuticals Receives Notice of Allowance from USPTO For Repirinast in Kidney Disease Patent
2024-11-04 18:31U:AGNPFNews ReleaseAlgernon Announces Warrant Extension
2024-08-20 07:00U:AGNPFNews ReleaseAlgernon Pharmaceuticals Announces Closing of Private Placement
2024-08-13 07:18U:AGNPFNews ReleaseAlgernon Pharmaceuticals Announces Increase to Private Placement
2024-08-07 17:02U:AGNPFNews ReleaseAlgernon Pharmaceuticals Announces Private Placement
2024-08-02 07:00U:AGNPFNews ReleaseAlgernon Pharmaceuticals Announces Closing of Private Placement
2024-07-31 07:00U:AGNPFNews ReleaseAlgernon Pharmaceuticals Announces Increase to Private Placement
2024-07-16 08:00U:AGNPFNews ReleaseAlgernon Pharmaceuticals Reports Results of Study Showing 93% Cough Suppression with Ifenprodil